United States · FDA National Drug Code directory
Acamprosate Calcium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0378-6333_e06868f1-f40b-4762-bd52-53a5ba825619
- Product NDC
- 0378-6333
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- acamprosate calcium enteric-coated
- Labeler
- Mylan Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140924
- Source listing expiry
- 20261231
Source-listed ingredients
- ACAMPROSATE CALCIUM — 333 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 180 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0378-6333-80) · 0378-6333-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →